Susquehanna International Group, LLP G1 Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$2.1 - $4.83 $1.32 Million - $3.03 Million	-627,762 Reduced 39.77%	950,839 $4.11 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $1.77 Million - $5.89 Million	1,578,601 New	1,578,601 $4.81 Million
Q2 2023 Aug 11, 2023	SELL	$2.46 - $3.14 $759,652 - $969,638	-308,802 Reduced 96.12%	12,471 $31,000
Q1 2023 May 16, 2023	SELL	$2.57 - $8.16 $145,253 - $461,195	-56,519 Reduced 14.96%	321,273 $861,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $1.06 Million - $2.75 Million	203,830 Added 117.17%	377,792 $2.05 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $563,705 - $1.85 Million	109,034 Added 167.93%	173,962 $2.17 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $139,246 - $293,314	-34,467 Reduced 34.68%	64,928 $321,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $754,991 - $1.09 Million	-99,341 Reduced 49.99%	99,395 $755,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $348,386 - $554,469	34,290 Added 20.85%	198,736 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $1.1 Million - $1.88 Million	83,653 Added 103.54%	164,446 $2.21 Million
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $1.03 Million - $1.39 Million	-52,651 Reduced 39.46%	80,793 $1.77 Million
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $1.4 Million - $2.59 Million	-79,470 Reduced 37.32%	133,444 $3.21 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $1.73 Million - $3.21 Million	157,546 Added 284.54%	212,914 $3.83 Million
Q3 2020 Nov 16, 2020	BUY	$11.55 - $23.75 $443,034 - $911,002	38,358 Added 225.5%	55,368 $640,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $87,182 - $222,010	-9,110 Reduced 34.88%	17,010 $413,000
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $150,407 - $436,464	16,583 Added 173.88%	26,120 $288,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $299,082 - $451,391	-14,561 Reduced 60.42%	9,537 $252,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $249,190 - $443,904	-10,939 Reduced 31.22%	24,098 $549,000
Q2 2019 Aug 16, 2019	BUY	$16.03 - $31.1 $403,491 - $782,818	25,171 Added 255.13%	35,037 $1.07 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $158,151 - $306,832	9,866 New	9,866 $302,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account